Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

No more poking! AI app sees inside wounds without contact

NCT ID NCT07211295

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a smartphone app called SeeWound 2 that uses artificial intelligence to measure the size, depth, and tissue makeup of hard-to-heal wounds. Instead of using a probe to touch the wound, the app takes a picture and calculates the measurements digitally. The study involved 25 adults with wounds from diabetes, poor circulation, or pressure, and aimed to see if the app is accurate and safe enough to replace the current invasive method.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

25 people

The number who actually took part.

Started

Jul 2025

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

ntended Use / Target Population The intended target population for SeeWound 2 comprises patients with hard-to-heal wounds. The device is designed for use by qualified healthcare professionals for the clinical assessment, documentation, and monitoring of chronic and complex wounds, including but not limited to venous leg ulcers, diabetic foot ulcers, and pressure ulcers. SeeWound 2 is intended to support clinical decision-making by providing objective, non-invasive measurements of wound surface area and depth, and by enabling the classification and quantification of wound bed tissue composition (slough and necrosis). The product is not intended to replace clinical judgement but to serve as an adjunctive tool to standard wound care practice.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Older than 18 years, men and women Difficult to heal wounds due to diabetes, VLU; Pressure wounds wound larger than 0.5 cm2 Exclusion Criteria: Exclusion Criteria / Contraindications Use of SeeWound 2 is not intended for, or is contraindicated in, the following situations: Patients under 18 years of age. Wounds located in anatomical regions where the full wound surface and depth cannot be captured (e.g. deep fistulas, tunnels, or undermined areas not accessible through surface imaging). Wounds with excessive exudation or infection that prevents adequate visual assessment. Patients who are unable or unwilling to provide informed consent. Patients with a known allergy or adverse reaction to any component used in the image acquisition process (where applicable). Wounds with specific identifiable attributes (e.g. on the face, or containing birthmarks or tattoos) where ethical considerations regarding data handling apply.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Difficult to heal wounds are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • BRIVA, Intensive Care for Burns,

    Linköping, Östergötland County, 58185, Sweden